Stock Jumps as U.K. Authorizes Gene Therapy

InvestorPlace - Stock Market News, Stock Advice & Trading Tips CRSP stock is up on U.K. authorization for its gene therapy treatment for sickle cell anemia. CRISPR hopes for FDA authorization next spring.